PrimeRFP SCOUT · Federal Contract Recompete Brief

VA25817J0061Chemistry covid19 IGG reagents — Ortho-Clinical Diagnostics, Inc

Ortho-Clinical Diagnostics, Inc holds $57.6M across 1,615 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent V797D60637. Competition previously drew 2 offers. PoP ended Sep 30, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

262-Network Contract Office 22 (36C262)

Awarding office

Ortho-Clinical Diagnostics, Inc

Recipient

Sep 30, 2021

PoP end

$-739,207.22

Obligated

$6.8M

Potential

334516

NAICS

6550

PSC

2 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho-Clinical Diagnostics, Inc — $90

Contract facts

Federal

Contract numberVA25817J0061

Also listed asVA258-17-J-0061

Also listed asV797D60637-VA25817J0061

Agency262-Network Contract Office 22 (36C262)

Awarding office262-Network Contract Office 22 (36C262)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentOrtho-Clinical Diagnostics, Inc

CAGE1C0L5

UEIJG5JF2JQJ121

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVV797D60637

Place of performanceALBUQUERQUE NM

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

Related solicitationVA258-16-Q-1011

PoP startOct 6, 2016

PoP end (current)Sep 30, 2021

Obligated$-739,207.22

Current value$6.8M

Potential value$6.8M

CHEMISTRY COVID19 IGG REAGENTS is a federal award for 262-Network Contract Office 22 (36C262) held by Ortho-Clinical Diagnostics, Inc. Estimated value $6.8M ($-739,207.22 obligated). Current period of performance ends Sep 30, 2021. Last award drew 2 bidders. Place of performance: ALBUQUERQUE NM. Related solicitation VA258-16-Q-1011.

Recompete timing

Public

● Past PoP end (1787 days ago)

Current PoP ended Sep 30, 2021 (1787 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ortho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($57.6M) · all agencies

Department of Veterans Affairs (VA)$26.2M · 45%Department of Defense (DOD)$22.1M · 38%Department of Health and Human Services (HHS)$8.6M · 15%General Services Administration (GSA)$297K · 1%

Open full company profile →

Related awards

Same parent · incumbent

75H71024F80169

FY2024 LAB VITROS7600 REAGENTS/SUPPLIES TO BE ORDERED ON AN "AS NEEDED" BASIS, PART OF CPT…

$2.1M

Aug 31, 2026

FA466121F0075

VITROS CHEMICAL ANALYZER MAINTENANCE AND CALIBRATION

$336K

Aug 31, 2026

36C25925N0518

BLOOD BANK GEL ANALYZER COST PER TEST - SLC

$114K

Sep 6, 2026

36C25025N0968

BLOOD BANK ANALYZER, REAGENTS AND CONSUMABLES

$239K

Sep 14, 2026

FA489721F0042

CHEM ANALYZER SERVICES - EXERCISE OPTION YEAR 1

$717K

Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract VA25817J0061?

VA25817J0061 (Chemistry covid19 IGG reagents) is a 262-Network Contract Office 22 (36C262) award with a potential value of $6.8M, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is VA258-17-J-0061?

VA258-17-J-0061 is the dashed form of PIID VA25817J0061 (Chemistry covid19 IGG reagents), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded VA25817J0061?

262-Network Contract Office 22 (36C262) awarded VA25817J0061 to Ortho-Clinical Diagnostics, Inc (potential $6.8M).

Who is the incumbent on VA25817J0061?

Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2021.

When does Ortho-Clinical Diagnostics, Inc’s VA25817J0061 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on VA25817J0061 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Apr 29, 2022